Pharmalink’s IND application for IgA Nephropathy now open with FDA

Sweden-based specialty pharma company Pharmalink has announced that its investigational new drug (IND) application for Nefecon is now open with the US Food and Drug Administration (FDA).

Category One, Showcase, status, Uncategorized, What's Hot